Cdk2 Polyclonal Antibody

CDK2 encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. Cyclin dependent kinase 2 is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants.

Introducing the CDK2 Polyclonal Antibody, a highly effective and reliable tool for the detection and analysis of Cyclin-dependent kinase 2 (CDK2) protein expression. This antibody is produced using a polyclonal approach, ensuring a high degree of specificity and sensitivity in detecting CDK2 protein in various biological samples.

The CDK2 Polyclonal Antibody is designed to recognize and bind to the CDK2 protein, a key regulator of the cell cycle and a critical component in the progression of various cancers. This antibody is suitable for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence assays.

With its exceptional performance and versatility, the CDK2 Polyclonal Antibody is an essential tool for researchers and scientists working in the fields of cancer biology, cell cycle regulation, and drug discovery. It is available in various sizes and formats to meet the diverse needs of different research applications.

In summary, the CDK2 Polyclonal Antibody is a high-quality and reliable reagent that offers exceptional performance and versatility in detecting and analyzing CDK2 protein expression. Its polyclonal nature ensures a high degree of specificity and sensitivity, making it an essential tool for researchers and scientists in various fields.